Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Euro: Downside risks with 1.1100 in sight against US Dollar – ING

Euro: Downside risks with 1.1100 in sight against US Dollar – ING

FXStreetFXStreet2026/10/06 07:54

Francesco Pesole at ING highlights that the Euro (EUR) is under pressure from French bond market turbulence, which is adding a fiscal risk premium and driving a repricing lower in European Central Bank (ECB) rate expectations. Swap differentials now resemble levels historically consistent with weaker EUR/USD. ING sees limited confidence in a sustained rebound and warns that EUR/USD could test 1.1100 or even 1.1000 if bond stress intensifies.

French fiscal fears weigh on Euro

"The euro started the week at the bottom of the G10 scorecard, a clear signal that turbulence in the French bond market remains firmly on FX investors’ radars. The euro is being affected through two channels: a direct one, where a fiscal risk premium (so far not extreme) has been added, and an indirect one via a repricing lower in ECB rate expectations."

"Pricing for the March ECB meeting has declined from 80bp on 24 September to 45bp now. This has been a very EUR-specific move and has pushed the EUR:USD two-year swap rate differential (ESTR-SOFR) to -167bp. The last time the spread was at these levels was in August 2025."

"Some relief in French bonds yesterday helped EUR/USD recover to just above 1.1200 after a fall to 1.1160, but we don’t have much confidence in a sustained rebound. The fiscal risk premium is still relatively limited, leaving scope for EUR/USD to test 1.1100 or even 1.1000 if bond market stress intensifies. Markets are now awaiting details from Marine Le Pen on a counter-budget."

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Hypertension drug developer Retension (RTSN.US) IPO priced at $11-13 per share, aiming to raise $40 million.

Retension Pharmaceuticals (RTSN.US) announced the terms of its initial public offering (IPO) on Monday.

智通财经•2026/10/06 09:16

Who will win? A bond storm sweeps through the US, Europe, and Japan, while global stock markets approach record highs

US Treasury yields have reached a peak of 5.31%, the highest since 2002, and European bond markets have fallen to multi-decade lows. Despite this global bond market turmoil, equities remain unfazed: the S&P 500 is approaching its historical high, with all of the “Magnificent Seven” tech stocks advancing, and the STOXX 600 index in Europe touched a new intraday record. Earnings growth, rather than valuation expansion, has become the core support for equities, while the ongoing wave of AI capital expenditure continues to attract funds. However, Ray Dalio has warned that the US debt cycle is nearing its limit, raising questions about how much further this divergence between stocks and bonds can continue.

华尔街见闻•2026/10/06 09:06
Who will win? A bond storm sweeps through the US, Europe, and Japan, while global stock markets approach record highs